Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis
Melinda Gooderham, Kim Papp, Nathalie Franchimont, Charles W Lynde et al.
Citations
34 citations
Journal
JAMA Dermatology
Topics
Psoriasis: Treatment and Pathogenesis
Field-Weighted Citation Impact (FWCI)
8.18
article
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis
Melinda Gooderham, Kim Papp, Nathalie Franchimont, Charles W Lynde, Catherine Maari, April Wang Armstrong, Vivian Laquer, Esha Gangolli, Lawrence Green, Graham Heap, Seth Forman, Xinyan Zhang, Wenwen Zhang, Bhaskar Srivastava, Jessamyn Blau, Yiwei Zhao
article en
34 citations
Abstract
No abstract available for this paper.
Publication Tag
JAMA DermatologyVol. 160(10)
Institutions
University of California, Los Angeles (US), University of Toronto (CA), George Washington University (US), Orange Coast Memorial Medical Center (US), Lynde Centre for Dermatology (CA), Probity Medical Research (CA), Innovaderm (Canada) (CA), Takeda (United States) (US)